Epidemiology of ATTRV30M neuropathy in Cyprus and the modifier effect of complement C1q on the age of disease onset

References

• Andrade C. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain. 1952;75:408–427.
   PubMed Web of Science ®Google Scholar
• Saraiva MJ, Birken S, Costa PP, et al. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest. 1984;74:104–119.
   PubMed Web of Science ®Google Scholar
• Conceicao I, De Carvalho M. Clinical variability in type I familial amyloid polyneuropathy (Val30Met): comparison between late- and early-onset cases in Portugal. Muscle Nerve. 2007;35:116–118.
   PubMed Web of Science ®Google Scholar
• Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry. 2012;83:152–158.
   PubMed Web of Science ®Google Scholar
• Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl. 1976;590:1–64.
   PubMedGoogle Scholar
• Araki S, Mawatari S, Ohta M, et al. Polyneuritic amyloidosis in a Japanese family. Arch Neurol. 1968;18:593–602.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Said G. Familial amyloid polyneuropathy. Lancet Neurol. 2011;10:1086–1097.
   PubMed Web of Science ®Google Scholar
• Reines JB, Vera TR, Martin MU, et al. Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llatzer Hospital descriptive study. Orphanet J Rare Dis. 2014;9:29.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Koutsou P, Papanicolaou EZ, et al. Epidemiological, clinical and genetic study of familial amyloidotic polyneuropathy in Cyprus. Amyloid. 2009;16:32–37.
   PubMed Web of Science ®Google Scholar
• Koike H, Misu K, Ikeda S, et al. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form]. Arch Neurol. 2002;59:1771–1776.
   PubMed Web of Science ®Google Scholar
• Reilly MM, Adams D, Booth DR, et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain. 1995;118:849–856.
   PubMed Web of Science ®Google Scholar
• Araki S, Ando Y. Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-). Proc Jpn Acad, Ser B, Phys Biol Sci. 2010;86:694–706.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Lalu T, Misrahi M, et al. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology. 1998;51:708–714.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Takei Y, Tokuda T, et al. Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan. Amyloid. 2003;1:39–47.
   Google Scholar
• Hafer-Macko CE, Dyck PJ, Koski CL. Complement activation in acquired and hereditary amyloid neuropathy. J Peripher Nerv Syst. 2000;5:131–139.
   PubMed Web of Science ®Google Scholar
• Dardiotis E, Koutsou P, Zamba-Papanicolaou E, et al. Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met. J Neurol Sci. 2009;284:158–162.
   PubMed Web of Science ®Google Scholar
• Pisalyaput K, Tenner AJ. Complement component C1q inhibits beta-amyloid- and serum amyloid P-induced neurotoxicity via caspase- and calpain-independent mechanisms. J Neurochem. 2008;104:696–707.
   PubMed Web of Science ®Google Scholar
• Panayiotou E, Fella E, Papacharalambous R, et al. C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy. PloS One. 2017;12:e0175767.
   PubMed Web of Science ®Google Scholar
• Antoniou AC, Sinilnikova OM, Simard J, et al. RAD51 135G–>C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet. 2007;81:1186–1200.
   PubMed Web of Science ®Google Scholar
• Barnes DR, Lee A, Investigators E, et al. Evaluation of association methods for analysing modifiers of disease risk in carriers of high-risk mutations. Genet Epidemiol. 2012;36:274–291.
   PubMed Web of Science ®Google Scholar
• Lange K, Weeks D, Boehnke M, et al. Programs for Pedigree Analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol. 1988;5:471–472.
   PubMed Web of Science ®Google Scholar
• Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018;57:829–837.
   PubMed Web of Science ®Google Scholar
• Sousa A, Andersson R, Drugge U, et al. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered. 1993;43:288–294.
   PubMed Web of Science ®Google Scholar
• Ikeda S, Nakazato M, Ando Y, et al. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. Neurology. 2002;58:1001–1007.
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet. 1994;31:351–354.
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, et al. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Povoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet. 1995;60:512–521.
   PubMed Web of Science ®Google Scholar
• Drugge U, Andersson R, Chizari F, et al. Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. J Med Genet. 1993;30:388–392.
   PubMed Web of Science ®Google Scholar
• Hellman U, Alarcon F, Lundgren HE, et al. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid 2008;15:181–186.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Ikeda S, Hanyu N, et al. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet. 1998;35:23–30.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve V, Carayol J, Ferreira A, et al. Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families. J Med Genet 2003;40:e120.
   PubMed Web of Science ®Google Scholar
• Bittencourt PL, Couto CA, Clemente C, et al. Phenotypic expression of familial amyloid polyneuropathy in Brazil. Eur J Neurol. 2005;12:289–293.
   PubMed Web of Science ®Google Scholar
• Fella E, Sokratous K, Papacharalambous R, et al. Pharmacological stimulation of phagocytosis enhances amyloid plaque clearance; evidence from a transgenic mouse model of ATTR neuropathy. Front Mol Neurosci 2017;10:138.
   PubMed Web of Science ®Google Scholar
• Trouw LA, Daha N, Kurreeman FA, et al. Genetic variants in the region of the C1q genes are associated with rheumatoid arthritis. Clin Exp Immunol. 2013;173:76–83.
   PubMed Web of Science ®Google Scholar
• Jo BS, Choi SS. Introns: The functional benefits of introns in genomes. Genomics Inform. 2015;13:112–118.
   PubMedGoogle Scholar
• Nylander PO, Beckman L, Holmgren G, et al. Association of C3 and C4A complement types with familial amyloidotic polyneuropathy. Hum Hered. 1990;40:272–277.
   PubMed Web of Science ®Google Scholar
• Zanusso GL, Moretto G, Bonetti B, et al. Complement neoantigen and vitronectin are components of plaques in amyloid AL neuropathy. Ital J Neurol Sci. 1992;13:493–499.
   PubMedGoogle Scholar
• Rafiq S, Frayling TM, Vyse TJ, et al. Assessing association of common variation in the C1Q gene cluster with systemic lupus erythematosus. Clin Exp Immunol. 2010;161:284–289.
   PubMed Web of Science ®Google Scholar
• Liphaus BL, Umetsu N, Jesus AA, et al. Molecular characterization of the complement C1q, C2 and C4 genes in Brazilian patients with juvenile systemic lupus erythematosus. Clinics. 2015;70:220–227.
   PubMed Web of Science ®Google Scholar